Showing results (81-90 of 338) with videos related to
Sort By:
Pageof 34
Revista Espanola De Cardiologia|March 26, 2008
[Prognostic value of electrocardiographic findings in hemodynamically stable patients with acute symptomatic pulmonary embolism]Carlos Escobar, David Jiménez, David Martí, et al.Journal of Comparative Effectiveness Research|September 22, 2015
Atrial fibrillation and chronic kidney disease: focus on rivaroxabanVivencio Barrios, José Luis GórrizJournal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 24, 2007
Regression of left ventricular hypertrophy by a candesartan-based regimen in clinical practice. The VIPE studyVivencio Barrios, Carlos Escobar, Alberto Calderón, et al.Clinical Drug Investigation|October 13, 2021
Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-AnalysisCarlos Escobar, Vivencio Barrios, Gregory Y H Lip, et al.Expert Review of Cardiovascular Therapy|February 7, 2025
The gut microbiota and its role in the development of cardiovascular diseaseCarlos Escobar, Xavier Aldeguer, David Vivas, et al.Journal of Clinical Lipidology|October 14, 2023
Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndromeCarlos Escobar, Vivencio Barrios, Angel Cequier, et al.Future Cardiology|May 4, 2022
Clinical and echocardiographic characteristics in patients with heart failure and type 2 diabetesMikel Jordhani, Joana Seiti, Vivencio BarriosAdvances in Therapy|May 22, 2012
Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trialsAlejandro de la Sierra, Vivencio BarriosExpert Review of Cardiovascular Therapy|July 1, 2011
Management of hypertension in diabetic patients: outstanding issuesMiguel Camafort-Babkowski, Vivencio Barrios, Antonio CocaMedicina (Kaunas, Lithuania)|October 28, 2023
Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN StudyVicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, et al.Pageof 34